Childhood Hematopoietic Cell Transplantation (PDQ®)–Health Professional Version

SECTIONS

Changes to This Summary (05/20/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Allogeneic Hematopoietic Cell Transplantation (HCT)

Added Other donor characteristics associated with outcome as a new subsection.

Added Horn et al. as reference 72 and level of evidence 2A.

Late Effects After HCT in Children

Added text about a study that showed that ovarian function preservation is better with reduced-intensity conditioning regimens (cited Panasiuk et al. as reference 128 and level of evidence 3iiiC).

This summary is written and maintained by the PDQ Pediatric Treatment Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summaryand PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Current Clinical Trials

Next section >
About This PDQ Summary